Fulminant myocarditis: COVID or not COVID? Reinfection or co-infection?
| Autor: | Roopa Rao, Sasikanth V. Adigopula, Smrity Upadhyay, Anjan Sinha, Jeffrey E. Everett, Sarada Uppuluri, Kashif Saleem, Ramya Yeleti, Maya Guglin, Kareem Ballut |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Viral Myocarditis Myocarditis Fulminant viruses Case Report fulminant myocarditis 030204 cardiovascular system & hematology Ventricular tachycardia 03 medical and health sciences 0302 clinical medicine VA ECMO Internal medicine medicine Humans 030212 general & internal medicine Impella biology Parvovirus business.industry Coinfection SARS-CoV-2 Cardiogenic shock cardiogenic shock COVID-19 coronavirus disease-19 biology.organism_classification medicine.disease Reinfection Cardiology biology.protein Molecular Medicine Antibody Cardiology and Cardiovascular Medicine business |
| Zdroj: | Future Cardiology |
| ISSN: | 1744-8298 |
| Popis: | We describe a unique case of fulminant myocarditis in a patient with presumed SARS-CoV-2 reinfection. Patient had initial infection 4 months backand had COVID-19 antibody at the time of presentation. Endomyocardial biopsy showed lymphocytic myocarditis, that is usually seen in viral myocarditis. The molecular diagnostic testing of the endomyocardial biopsy for cardiotropic viruses was positive for Parvovirus and negative for SARS-CoV-2. Authors highly suspect co-infection of SARS-CoV-2 and Parvovirus, that possibly triggered the immune cascade resulting in fulminant myocarditis. Patient was hemodynamically unstable with ventricular tachycardia and was supported on VA ECMO and Impella CP. There was impressive recovery of left ventricular function within 48 h, leading to decannulation of VA ECMO in 72 h. This unique case was written by the survivor herself. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|